Top of this page
Skip navigation, go straight to the content
FAQs
Answers to our investors' frequently asked questions:
What are the major shareholders of UCB?
| UCB Controlling and Important Shareholders as of 4 April 2007 | ||
|---|---|---|
| Capital € | 550,083,756 | |
| Shares (outstanding) | 183,361,252 | |
| 1 | Financière de Tubize SA | 36.20% |
| 2 | Schwarz Vermögensverwaltung GmbH | 5.39% |
| 3 | KBC Bank NV | 1.25% |
| 4 | Banque Degroof SA through Degroof Corporate Finance SA and through Imofig SA | 0.36% |
| 5 | Levimmo SA | 0.67% |
| 6 | Compar Finance SA | 1.04% |
| 7 | Patrinvest SCA | 1.04% |
| Tubize + concert : 2,3,4,5,6 and 7 | 45.94% | |
| 8 | Eupac (EuroPacific Fund) | 4.99% |
Tubize has declared acting in concert with each of the shareholders 2,3,4,5,6 and 7.
The remaining of UCB shares are held by the public.
Your questions our answers
- When was UCB founded?
- What are UCB main areas of activities?
- How many people does the new UCB employ?
- What are the group key figures?
- What are UCB's topselling products during the first half 2007?
- On which accounting standards are the consolidated financial statements of the UCB group based?
- How is the fiscal year defined?
- Does UCB reports quarterly?
- When will the next shareholders' meeting take place?
- Amount and date of the current dividend?
- What are the major shareholders of UCB?
- How many UCB shares are outstanding?
- Does UCB have ADR (American Depositary Receipt)?
- What is UCB's position with respect to the Corporate Governance principles?
- How can I order UCB annual reports?
- As a former Celltech shareholder, how can I return my shares to UCB?
- As a Schwarz Pharma shareholder, how and when can I return my shares to UCB SP GmbH?
